コンテンツにジャンプ

トップページ > 各部紹介 > 国際政策研究部 > 研究業績

研究業績

  1. Saito, E., T. Yano, M. Hori, D. Yoneoka, T. Matsuda, Y. Chen, and K. Katanoda, Is young-onset esophageal adenocarcinoma increasing in Japan? An analysis of population-based cancer registries. Cancer Med, 2022. 11(5): p. 1347-1356.
  2. Nguyen, P.T., K. Katanoda, E. Saito, M. Hori, T. Nakayama, and T. Matsuda, Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach. Int J Cancer, 2022.
  3. Nakata, K., E. Hiyama, K. Katanoda, T. Matsuda, Y. Tada, M. Inoue, K. Kawa, M. Maru, C. Shimizu, K. Horibe, and I. Miyashiro, Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy. Int J Clin Oncol, 2022. 27(1): p. 7-15.
  4. Kawakita, D., I. Oze, S. Iwasaki, T. Matsuda, K. Matsuo, and H. Ito, Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan. Cancer Med, 2022.
  5. Inoue, M., M. Hirabayashi, S.K. Abe, K. Katanoda, N. Sawada, Y. Lin, J. Ishihara, R. Takachi, C. Nagata, E. Saito, A. Goto, K. Ueda, J. Tanaka, M. Hori, T. Matsuda, and P.A.F.J.C. Cancer, Burden of cancer attributable to modifiable factors in Japan in 2015. Glob Health Med, 2022. 4(1): p. 26-36.
  6. Pilleron, S., N. Alqurini, J. Ferlay, K.R. Haase, M. Hannan, M. Janssen-Heijnen, K. Kantilal, K. Katanoda, C. Kenis, G. Lu-Yao, T. Matsuda, E. Navarrete, N. Nikita, M. Puts, F.J. Strohschein, and E.J.A. Morris, International trends in cancer incidence in middle-aged and older adults in 44 countries. J Geriatr Oncol, 2021.
  7. Stacchiotti, S., A.M. Frezza, J.Y. Blay, E.H. Baldini, S. Bonvalot, J. Bovee, D. Callegaro, P.G. Casali, R.C. Chiang, G.D. Demetri, E.G. Demicco, J. Desai, M. Eriksson, H. Gelderblom, S. George, M.M. Gounder, A. Gronchi, A. Gupta, R.L. Haas, A. Hayes-Jardon, P. Hohenberger, K.B. Jones, R.L. Jones, B. Kasper, A. Kawai, D.G. Kirsch, E.S. Kleinerman, A. Le Cesne, J. Lim, M.D. Chirlaque Lopez, R. Maestro, R. Marcos-Gragera, J. Martin Broto, T. Matsuda, O. Mir, S.R. Patel, C.P. Raut, A.R.A. Razak, D.R. Reed, P. Rutkowski, R.G. Sanfilippo, M. Sbaraglia, I.M. Schaefer, D.C. Strauss, K. Sundby Hall, W.D. Tap, D.M. Thomas, W.T.A. van der Graaf, W.J. van Houdt, O. Visser, M. von Mehren, A.J. Wagner, B.A. Wilky, Y.J. Won, C.D.M. Fletcher, A.P. Dei Tos, and A. Trama, Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer, 2021.
  8. Soerjomataram, I., A. Bardot, J. Aitken, M. Pineros, A. Znaor, E. Steliarova-Foucher, B. Kohler, M. Bettio, T. Matsuda, M. de Camargo Cancela, L. Mery, and F. Bray, Impact of the COVID-19 pandemic on population-based cancer registry. Int J Cancer, 2021.
  9. Matsuda, T. and H. Charvat, Age-specific testis cancer incidence rate in the world. Jpn J Clin Oncol, 2021. 51(6): p. 1019-1020.
  10. Matsuda, T., Moving from collective to distributed epidemiological cancer research. Lancet Respir Med, 2021. 9(9): p. 945-947.
  11. Lombe, D., R. Sullivan, C. Caduff, Z. Ali, N. Bhoo-Pathy, J. Cleary, M. Jalink, T. Matsuda, D. Mukherji, D. Sarfati, V. Vanderpuye, A. Yusuf, and C. Booth, Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic. Ecancermedicalscience, 2021. 15: p. 1202.
  12. Katanoda, K., M. Hori, E. Saito, A. Shibata, Y. Ito, T. Minami, S. Ikeda, T. Suzuki, and T. Matsuda, Updated trends in cancer in Japan: incidence in 1985-2015 and mortality in 1958-2018 - a sign of decrease in cancer incidence. J Epidemiol, 2021.
  13. Gatellier, L., A. Shankar, L.K.M. Dewi, Q.M. Hussain, T. Dendup Wangdi, D.B. Sukumaran, N.K. Sari, S. Tavakkoli Shiraji, M. Biglari, M. Tahmasebi, S. Iwata, T. Suzuki, S.K. Myung, J.Y. Chun, J.S. Han, F.N. Lau, S. Yusak, L. Bayarsaikhan, K.T. Mu, K.K. Pradhananga, A. Yusuf, C.H. Lin, R.C. Chiang, S. Sangrajran, Q.T. Nguyen, G.N. Huong, A.N. Soe, D.N. Sharma, M. Sengar, C.S. Pramesh, T. Matsuda, A.M. Jarrahi, and W. Hwang, The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres. Asian Pac J Cancer Prev, 2021. 22(3): p. 681-690.
  14. Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Guren MG, Tervonen H, Little A, O’Connell DL, Gavin A, De P, Aagaard Thomsen L, Moller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I. Age disparities in stage-specific colon cancer survival across seven countries: an ICBP SURVMARK-2 population-based study. Int J Cancer 2021;148(7):1575-1585 (doi: 10.1002/ijc.33326).
  15. Miranda-Filho A, Bray F, Charvat H, Rajaraman S, Soerjomataram I. The world cancer patient population (WCPP): an updated standard for international comparisons of population-based survival. Cancer Epidemiol 2020;69:101802 (doi: 10.1016/j.canep.2020.101802).
  16. Charvat H, Shimazu T, Inoue M, Iwasaki M, Sawada N, Yamaji T, Tsugane S; JPHC Study Group. Estimation of the performance of a risk prediction model for gastric cancer occurrence in Japan: evidence from a small external population. Cancer Epidemiol 2020;67:101766 (doi: 10.1016/j.canep.2020.101766).
  17. Wei, W., H. Zeng, R. Zheng, S. Zhang, L. An, R. Chen, S. Wang, K. Sun, T. Matsuda, F. Bray, and J. He, Cancer registration in China and its role in cancer prevention and control. Lancet Oncol, 2020. 21(7): p. e342-e349.
  18. Matsuda, T., Y.J. Won, R. Chun-Ju Chiang, J. Lim, K. Saika, K. Fukui, W.C. Lee, L. Botta, A. Bernasconi, and A. Trama, Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia. Cancer Epidemiol, 2020. 67: p. 101702.
  19. Gatellier, L., T. Matsuda, K. Sabapathy, M. Dai, L.K.M. Dewi, T.T. Huong, K. Kardinah, T.V. Thuan, J.B. Park, J. He, E. Nansalmaa, B. Luvsandorj, W.Y.K. Hwang, M. Sengar, C.S. Pramesh, and T. Suzuki, An Asian Body to Tackle Cancers in Asia - The Asian National Cancer Centers Alliance. Asian Pac J Cancer Prev, 2020. 21(5): p. 1207-1212.
  20. Matsuda, T. and M. Inoue, Moving towards tailored, region-specific cancer-control measures in China. Lancet Glob Health, 2019. 7(2): p. e175-e176.
  21. Nakata, K., Y. Ito, W. Magadi, A. Bonaventure, C.A. Stiller, K. Katanoda, T. Matsuda, I. Miyashiro, K. Pritchard-Jones, and B. Rachet, Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010). Cancer Sci, 2018. 109(2): p. 422-434.
  22. Allemani, C., T. Matsuda, V. Di Carlo, R. Harewood, M. Matz, M. Niksic, A. Bonaventure, M. Valkov, C.J. Johnson, J. Esteve, O.J. Ogunbiyi, E.S.G. Azevedo, W.Q. Chen, S. Eser, G. Engholm, C.A. Stiller, A. Monnereau, R.R. Woods, O. Visser, G.H. Lim, J. Aitken, H.K. Weir, M.P. Coleman, and C.W. Group, Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet, 2018. 391(10125): p. 1023-1075.
  23. Nakata, K., Y. Ito, W. Magadi, A. Bonaventure, C.A. Stiller, K. Katanoda, T. Matsuda, I. Miyashiro, K. Pritchard-Jones, and B. Rachet, Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010). Cancer Sci, 2017.
各部紹介
予防研究部
疫学研究部
検診研究部
検診開発研究部
データサイエンス研究部
行動科学研究部
サバイバーシップ研究部
コホート研究部
生物統計研究部
生命倫理・医事法研究部
国際政策研究部
がん情報提供部
がん医療支援部
がん政策評価研究部
医療政策部
がん登録センター